Zhanli Wang
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Small Animals top 2%
- Brucella: diagnosis, epidemiology, treatment
Papers in
-
- Gut microbiota and health 5
- Extracellular vesicles in disease 4
-
- Quinazolinone synthesis and applications 4
- Synthesis and biological activity 4
- Co-authors
- Hongwei Jin (8 shared papers)Hui Yu (3 shared papers)Huaping Liang (3 shared papers)Heping Zhang (2 shared papers)Danliang Ho (1 shared paper)Zhuang Guo (1 shared paper)Jianmin Qiao (1 shared paper)Yuan Kun Lee (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Current Medicinal Chemistry (3 papers)BioMed Research International (2 papers)PLoS ONE (2 papers)Human Brain Mapping (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Zhanli Wang
59 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 122
- Nephrology 155
- Small Animals 129
- Pharmacology 75
- Molecular Biology 602
- Cancer Research 91
Countries citing papers authored by Zhanli Wang
This map shows the geographic impact of Zhanli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanli Wang more than expected).
Fields of papers citing papers by Zhanli Wang
This network shows the impact of papers produced by Zhanli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanli Wang. The network helps show where Zhanli Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhanli Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 303 | |
| 2 | 2013 | 151 | |
| 3 | 2023 | 58 | |
| 4 | 2014 | 58 | |
| 5 | 2012 | 56 | |
| 6 | 2019 | 52 | |
| 7 | 1999 | 51 | |
| 8 | 2010 | 47 | |
| 9 | 2021 | 39 | |
| 10 | 2016 | 30 | |
| 11 | 2019 | 29 | |
| 12 | MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival. | 2018 | 28 |
| 13 | 2022 | 27 | |
| 14 | 2007 | 26 | |
| 15 | 2006 | 26 | |
| 16 | 2019 | 23 | |
| 17 | 2012 | 22 | |
| 18 | 2017 | 22 | |
| 19 | 2020 | 18 | |
| 20 | 2011 | 17 |
About Zhanli Wang
Zhanli Wang is a scholar working on Molecular Biology, Organic Chemistry, Small Animals, Genetics and Immunology, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Brucella: diagnosis, epidemiology, treatment (7 papers), Gut microbiota and health (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Quinazolinone synthesis and applications (4 papers), Computational Drug Discovery Methods (4 papers), Synthesis and biological activity (4 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Nephrology (155 citations), Small Animals (129 citations), Pharmacology (75 citations), Molecular Biology (602 citations) and Cancer Research (91 citations). Zhanli Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Hongwei Jin, Hui Yu, Huaping Liang, Hui Yu, Heping Zhang, Danliang Ho, Zhuang Guo, Jianmin Qiao, Yuan Kun Lee and Qiangchuan Hou. Their work appears in journals such as Biochemical and Biophysical Research Communications, Current Medicinal Chemistry, BioMed Research International, PLoS ONE and Human Brain Mapping.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.